Both METTL14 and YTHDF2 exhibit low expression in lung cancer but are positively correlated with better patient prognosis, suggesting that impaired METTLE14-YTHDF2 activity contributes to the downregulation of KCTD10 in lung cancer. This evidence concerns the gene KCTD10 and lung cancer.